These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 16364844

  • 1. Changes in myocardial vasoreactivity after drastic reduction of plasma fibrinogen and cholesterol: a clinical study in long-term heart transplant survivors using positron emission tomography.
    Jaeger BR, Bengel FM, Odaka K, Uberfuhr P, Labarrere CA, Bengsch S, Engelschalk C, Kreuzer E, Reichart B, Schwaiger M, Seidel D.
    J Heart Lung Transplant; 2005 Dec; 24(12):2022-30. PubMed ID: 16364844
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Evidence for maximal treatment of atherosclerosis: drastic reduction of cholesterol and fibrinogen restores vascular homeostasis.
    Jaeger BR.
    Ther Apher; 2001 Jun; 5(3):207-11. PubMed ID: 11467757
    [Abstract] [Full Text] [Related]

  • 4. [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy].
    Seidel D.
    Z Kardiol; 2003 Jun; 92(Suppl 3):III6-27. PubMed ID: 14663597
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Aggressive lowering of fibrinogen and cholesterol in the prevention of graft vessel disease after heart transplantation.
    Jaeger BR, Meiser B, Nagel D, Uberfuhr P, Thiery J, Brandl U, Brückner W, von Scheidt W, Kreuzer E, Steinbeck G, Reichart B, Seidel D.
    Circulation; 1997 Nov 04; 96(9 Suppl):II-154-8. PubMed ID: 9386091
    [Abstract] [Full Text] [Related]

  • 7. Long-term prevention of premature coronary atherosclerosis in homozygous familial hypercholesterolemia.
    Jaeger BR, Tsobanelis T, Bengel F, Schwaiger M, Seidel D.
    J Pediatr; 2002 Jul 04; 141(1):125-8. PubMed ID: 12091863
    [Abstract] [Full Text] [Related]

  • 8. LDL-apheresis: clinical experience and indications in the treatment of severe hypercholesterolemia.
    Thiery J, Seidel D.
    Transfus Sci; 1993 Jul 04; 14(3):249-59. PubMed ID: 10146336
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Single lipoprotein apheresis session improves cardiac microvascular function in patients with elevated lipoprotein(a): detection by stress/rest perfusion magnetic resonance imaging.
    Bohl S, Kassner U, Eckardt R, Utz W, Mueller-Nordhorn J, Busjahn A, Thomas HP, Abdel-Aty H, Klingel R, Marcovina S, Dietz R, Steinhagen-Thiessen E, Schulz-Menger J, Vogt A.
    Ther Apher Dial; 2009 Apr 04; 13(2):129-37. PubMed ID: 19379152
    [Abstract] [Full Text] [Related]

  • 11. Shear stress-dependent platelet function after LDL cholesterol apheresis.
    Spieker LE, Ruschitzka F, Badimon JJ, Noll G, Corti R.
    Thromb Res; 2004 Apr 04; 113(6):395-8. PubMed ID: 15226094
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of sudden hearing loss through Fibrinogen/LDL-apheresis. A prospective, randomized multicenter trial].
    Suckfüll M, Seidel D, Thiery J, Mazurek B, Jaehne M, Gronemeyer J, Reichel O, Sasama J, Kichigina S, Möller M, Beil FU, Schrameyer-Wernecke A, Kassner U, Koch M, Jaeger B, Osterkorn K, Osterkorn D.
    Z Kardiol; 2003 Apr 04; 92(Suppl 3):III59-63. PubMed ID: 14663604
    [Abstract] [Full Text] [Related]

  • 13. Heparin-Induced extracorporeal low-density lipoprotein precipitation apheresis: a new therapeutic concept in the treatment of sudden hearing loss.
    Suckfüll M.
    Ther Apher; 2001 Oct 04; 5(5):377-83. PubMed ID: 11778923
    [Abstract] [Full Text] [Related]

  • 14. [Myocardial perfusion under H.E.L.P. -apheresis. Objectification by PET].
    Mellwig KP, Baller D, Schmidt HK, V Buuren F, Wielepp JP, Burchert W, Horstkotte D.
    Z Kardiol; 2003 Oct 04; 92(Suppl 3):III30-7. PubMed ID: 14663599
    [Abstract] [Full Text] [Related]

  • 15. [H.E.L.P. apheresis and oxidative stress].
    Pulawski E, Mellwig KP, Horstkotte D.
    Z Kardiol; 2003 Oct 04; 92(Suppl 3):III38-41. PubMed ID: 14663600
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Heparin-induced extracorporeal LDL precipitation (HELP) in therapy refractory hypercholesterolemia and coronary heart disease: effect on clinical and morphological regression of coronary sclerosis].
    Schuff-Werner P.
    Z Kardiol; 1997 Oct 04; 86 Suppl 1():57-64. PubMed ID: 9173722
    [Abstract] [Full Text] [Related]

  • 18. Improvement of endothelium-dependent coronary vasodilation after a single LDL apheresis in patients with hypercholesterolemia.
    Igarashi K, Tsuji M, Nishimura M, Horimoto M.
    J Clin Apher; 2004 Oct 04; 19(1):11-6. PubMed ID: 15095396
    [Abstract] [Full Text] [Related]

  • 19. LDL-apheresis accelerates the recovery of nonarteritic acute anterior ischemic optic neuropathy.
    Ramunni A, Giancipoli G, Guerriero S, Lapenna L, Saracino A, Saliani MT, Capurso A, Sborgia C, Coratelli P.
    Ther Apher Dial; 2005 Feb 04; 9(1):53-8. PubMed ID: 15828907
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of low-density lipoprotein apheresis in patients with peripheral arterial occlusive disease undergoing hemodialysis treatment.
    Morimoto S, Yano Y, Maki K, Sawada K, Iwasaka T.
    Am J Nephrol; 2007 Feb 04; 27(6):643-8. PubMed ID: 17878713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.